TerminatedNCT03209778
Involuntary Memories Investigation in Schizophrenia
This study ended early.
In StrasbourgSchizophreniaInterventional studyAges 18–55
Schizophrenia studies
Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
TerminatedNCT03817528
ITI-007 (Lumateperone Tosylate) for Schizophrenia
This study ended early.
In New YorkSchizophreniaMedication studyAges 18–60
TerminatedNCT00947375
Lamictal TM, Haloperidol Decanoate in Schizophrenia
Official study title
The Effect of Lamictal TM Augmentation of Haloperidol Decanoate in the Treatment of Resistant Schizophrenia Predominantly by Verbal Resistant Hallucinosis: Randomized, Double-blind, Placebo-controlled, Study
This study ended early.
In BakuSchizophreniaMedication studyAges 18–60
TerminatedNCT01943019
Linagliptin in Schizophrenia Patients
What is this study about?
Researchers are studying Linagliptin to find out how it affects psychotic symptoms in people with schizophrenia.
This study ended early.
In Bandar Tun RazakSchizophreniaMedication studyAges 18–65
CompletedNCT02203838
Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia
What is this study about?
Researchers studied RBP-7000, tracking side effects to assess long-term safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockSchizophreniaMedication studyAges 18–65
CompletedNCT02918825
Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia
Official study title
A Randomized Trial to Compare the Efficiency and Side Effect Between Olanzapine and Long-acting Paliperidone Palmitate Injection in Schizophrenia
This study has finished and is no longer accepting participants.
In BeijingSchizophreniaMedication studyAges 18–45
CompletedNCT02743143
Long-Term Exercise Training Therapy Versus Usual Care in people with Schizophrenia
Official study title
Effectiveness of 1 Year Supervised Exercise Training Versus Usual Care on Cardiovascular Health, Functional Skills and Physical Fitness in Patients With Schizophrenia
This study has finished and is no longer accepting participants.
In TrondheimSchizophreniaBehavioural studyAges 18+
TerminatedNCT01834638
Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)
What is this study about?
Researchers are studying ABT-126, tracking side effects to assess long-term safety in people with schizophrenia.
This study ended early.
Multiple locations, including ChinoSchizophreniaMedication studyAges 20–66
TerminatedNCT01760993
Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia
What is this study about?
This study evaluates the safety of SPD489 for people with schizophrenia.
This study ended early.
Multiple locations, including Oklahoma CitySchizophreniaMedication studyAges 18–65
CompletedNCT03304457
Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia
Official study title
Effect of Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in First Episode Untreated Schizophrenia: A Randomized, Open Label, Active Controlled Study
This study has finished and is no longer accepting participants.
In BhubaneswarSchizophreniaMedication studyAges 18–45
CompletedNCT03376763
MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
What is this study about?
Researchers studied Abilify maintena to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including GongjuSchizophreniaMedication studyAges 19–64
TerminatedNCT00148590
Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in people with Acute Schizophrenia
Official study title
Memantine add-on to Risperidon for Treatment of Negative Symptoms and Cognitive Dysfunction in Patients With Acute Schizophrenia: Results of a Proof of Concept Study
This study ended early.
In BerlinSchizophreniaMedication studyAges 18–40
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.